Evidence map›Paper›PMID 32595809›Full record

ArticleCardiology research2020

Association of Potentially Inappropriate Medications With All-Cause Mortality in the Elderly Acute Decompensated Heart Failure Patients: Importance of Nonsteroidal Anti-Inflammatory Drug Prescription.

Tomiko Sunaga, Azusa Yokoyama, Shoko Nakamura, Nagisa Miyamoto, Saki Watanabe, Miki Tsujiuchi, Sakura Nagumo, Ayaka Nogi, Hideyuki Maezawa, Takuya Mizukami and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Cardiology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation.American heart journal plus : cardiology research and practice · 2022
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Tomiko SunagaDepartment of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Azusa YokoyamaDepartment of Pharmacy, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Shoko NakamuraDepartment of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Nagisa MiyamotoDepartment of Pharmacy, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Saki WatanabeDivision of Pharmaceutics, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa University, Tokyo, Japan.
Miki TsujiuchiDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Sakura NagumoDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Ayaka NogiDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Hideyuki MaezawaDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Takuya MizukamiDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Mio EbatoDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Hiroshi SuzukiDivision of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Akihiro NakamuraDivision of Pharmaceutics, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa University, Tokyo, Japan.
Toru WatanabeDepartment of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Tadanori SasakiDepartment of Hospital Pharmaceutics, School of Pharmacy, Showa University, Tokyo, Japan.
Showa University Fujigaoka Hospital · JPShowa University Hospital · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute decompensated heart failure (ADHF) is the most common cause of readmissions in the hospital. ADHF patients are associated with polypharmacy. It is a common problem among elderly patients due to frequently occurring multiple morbidities and is associated with the use of potentially inappropriate medications (PIMs). The aim of this study was to examine the association between PIMs and all-cause mortality in elderly ADHF patients.

methodsThis retrospective study included ADHF patients who were admitted to the Showa University Fujigaoka Hospital between January 2015 and August 2016. We investigated the proportion of patients taking at least one PIM at admission and the characteristics of patients at admission. PIMs were defined based on the Screening Tool of Older People's potentially inappropriate Prescriptions (STOPP). Multiple Cox regression analysis was performed to examine the association between PIM use and all-cause mortality.

resultsA total of 193 elderly patients (median age 81 years, interquartile range (IQR) 65 - 99 years) were included in the study. All-cause death occurred in 30 patients. The median number of medications at admission was 7 (IQR 0 - 18). The number of medications (greater than or equal to six) at admission was associated with mortality. Multivariate Cox regression analysis revealed that systolic blood pressure (SBP) < 100 mm Hg at admission, chronic obstructive pulmonary disease (COPD), and use of non-steroidal anti-inflammatory drugs (NSAIDs) at admission were independent predictors for all-cause mortality.

conclusionsThe medical staff should attempt to stop unnecessary medications that are prone to be inappropriate prescribing. In particular, prescription of NSAIDs should be carefully assessed and monitored.

Indexed as

Elderly heart failureNon-steroidal anti-inflammatory drugsPotentially inappropriate medicationsPrognosisSTOPP criteria

Identifiers

PMID32595809
PMCPMC7295559
OpenAlexW3033873670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.